PMID- 27234751
OWN - NLM
STAT- MEDLINE
DCOM- 20170106
LR  - 20181202
IS  - 1873-2623 (Electronic)
IS  - 0041-1345 (Linking)
VI  - 48
IP  - 3
DP  - 2016 Apr
TI  - Outcomes of Kidney Transplantations Under the Philippine Health Insurance 
      Corporation's Type Z Benefit Package at the National Kidney and Transplant 
      Institute, Philippines.
PG  - 852-4
LID - S0041-1345(16)00214-1 [pii]
LID - 10.1016/j.transproceed.2015.12.095 [doi]
AB  - BACKGROUND: Under the Universal Health Care Program of the Department of Health, 
      the Philippine Health Insurance Corporation (PHIC) launched the Case Type Z 
      benefit package for kidney transplantation, providing the largest amount (USD 
      $13,300.00) for any single medical procedure. The objective of this study was to 
      describe under the PHIC Case Type Z Benefit Package for kidney transplantation at 
      the National Kidney and Transplant Institute and kidney transplantation outcomes 
      under this package. METHODS: Included in the benefit were standard risk 
      recipients between 10 and 70 years of age with at least 1 human leukocyte antigen 
      (HLA) DR match with the donor, panel-reactive antibody (PRA) less than 20%, and 
      absence of donor-specific antibody (DSA). Previous transplantations, malignancy, 
      hepatitis B and C, human immunodeficiency virus (HIV) positivity, cytomegalovirus 
      (CMV) R-/D+, congestive heart failure, and liver cirrhosis were exclusion 
      criteria. Patients were evaluated by a medical social worker according to their 
      family's financial status. RESULTS: Since June 2012, a total of 261 patients have 
      received the benefit, with 44 under service, 37 with fixed co-pay and 180 with 
      variable co-pay. Of the living donor kidney transplants, 98% had immediate graft 
      function, with 2.3% (6/261) acute rejection rates at 1 year. The total cost of 
      hospitalization was within the benefit for living donor kidney transplants (less 
      than USD 8000.00) but exceeded it in all cases of deceased donor kidney 
      transplants. CONCLUSIONS: The successful use of and excellent outcomes under the 
      Case Type Z benefit demonstrated how collaboration among government agencies, 
      health care providers, and pharmaceutical companies could result in a program 
      that improved the access to health care for Filipino patients with end-stage 
      renal disease.
CI  - Copyright (c) 2016 Elsevier Inc. All rights reserved.
FAU - Pamugas, G E P
AU  - Pamugas GE
AD  - Department of Adult Nephrology, National Kidney and Transplant Institute, Quezon 
      City, Philippines.
FAU - Arakama, M-H I
AU  - Arakama MH
AD  - Department of Adult Nephrology, National Kidney and Transplant Institute, Quezon 
      City, Philippines.
FAU - Danguilan, R A
AU  - Danguilan RA
AD  - Department of Adult Nephrology, National Kidney and Transplant Institute, Quezon 
      City, Philippines. Electronic address: dr.radanguilan@gmail.com.
FAU - Ledesma, D
AU  - Ledesma D
AD  - Human Organ Preservation Effort, National Kidney and Transplant Institute, Quezon 
      City, Philippines.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Transplant Proc
JT  - Transplantation proceedings
JID - 0243532
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Child
MH  - Deductibles and Coinsurance
MH  - Female
MH  - Graft Survival
MH  - Hospitalization/economics
MH  - Humans
MH  - Kidney Transplantation/*economics
MH  - Living Donors
MH  - Male
MH  - Middle Aged
MH  - Philippines
MH  - Retrospective Studies
MH  - *Universal Health Insurance
MH  - Young Adult
EDAT- 2016/05/29 06:00
MHDA- 2017/01/07 06:00
CRDT- 2016/05/29 06:00
PHST- 2015/11/30 00:00 [received]
PHST- 2015/12/30 00:00 [accepted]
PHST- 2016/05/29 06:00 [entrez]
PHST- 2016/05/29 06:00 [pubmed]
PHST- 2017/01/07 06:00 [medline]
AID - S0041-1345(16)00214-1 [pii]
AID - 10.1016/j.transproceed.2015.12.095 [doi]
PST - ppublish
SO  - Transplant Proc. 2016 Apr;48(3):852-4. doi: 10.1016/j.transproceed.2015.12.095.